WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: THE GENE TO ANTIBODY COMPANY

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on THE GENE TO ANTIBODY COMPANY

Mark Identification

Proof of use for THE GENE TO ANTIBODY COMPANY

We do not have any records of a proof of use for THE GENE TO ANTIBODY COMPANY at this moment.

Click here to add a proof of use for THE GENE TO ANTIBODY COMPANY

Possible trademark infringements of THE GENE TO ANTIBODY COMPANY

Basic Information about THE GENE TO ANTIBODY COMPANY

Serial Number
97382404
Filing Date
26 Apr 2022
Registration Number
7264779
Registration Date
02 Jan 2024
Mark Drawing Code
4

Classifications

Declare the trademark use of THE GENE TO ANTIBODY COMPANY on the blockchain with WikiTrademarks.io.

First use of THE GENE TO ANTIBODY COMPANY anywhere
THE GENE TO ANTIBODY COMPANY was first used on 01 Nov 2020 for the primary classification of goods and services, international, 040 (Treatment of materials)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
040
US Codes
100; 103; 106
First use of THE GENE TO ANTIBODY COMPANY anywhere
THE GENE TO ANTIBODY COMPANY was first used on 01 Nov 2020 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
042
US Codes
100; 101

Who owns THE GENE TO ANTIBODY COMPANY?

Correspondent

Thomas Kading
FARGO PATENT AND BUSINESS LAW, PLLC
2605 42ND ST. S
2605 42ND ST. S

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on THE GENE TO ANTIBODY COMPANY